Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 15079022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antiplatelet drugs (APD) are widely used in the prevention of ischemic cardio- and cerebrovascular diseases. The authors studied the frequency of stroke occurring after APD discontinuation, the cause of discontinuation, and the delay between APD disruption and stroke. Only 4.49% of strokes were related to a recent APD discontinuation, but all cases occurred between 6 and 10 days after drug discontinuation (p < 0.0001). This temporal pattern has biologic plausibility because the inhibited platelets circulate in the blood for about 10 days.
Medical subject headings
- Brain Ischemia
- Platelet Aggregation Inhibitors
- Stroke
- Substance Withdrawal Syndrome